Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Diabetes Care 47:13501359 Naaman SC, Bakris GL (2023) Diabetic nephropathy: update on pillars of therapy slowing progression
Also, the product is very pricey
Tirzepatide is currently being tested in a similar trial of patients with HFpEF and obesity in the SUMMIT trial (Study of Tirzepatide in Participants with Heart Failure With Preserved Ejection Fraction and Obesity), which has a primary hierarchical end point of death, HF events, change in 6-minute walk test distance and change in KCCQ score
If you experience frequent UTIs, your doctor may recommend additional tests to check for underlying issues such as bladder dysfunction or kidney problems
However, clinical outcomes may depend partly on individual adherence without structured behavioral support
